The supplementation of SAMe can regulate the genes related to fat and glucose metabolism by inhibiting the expression of transcription factor PPAR-γ, followed by modulating the downstream genes, so as to change the intracellular lipid metabolism, to regulate glucose homeostasis, and to inhibit the accumulation of intracellular triglycerides, thus possibly preventing metabolic syndrome. This evidence concerns the gene PPARG and metabolic syndrome.